-
Therapeutic antibody engineering for efficient targeted degradation of membrane proteins in lysosomes
-
Cation-independent mannose 6-phosphate receptor: From roles and functions to targeted therapies
-
Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins
-
Mannose 6-phosphate receptor-targeting antibodies preserve Fc receptor-mediated recycling
-
The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics
-
Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease
-
Topological requirements for CI-M6PR-mediated cell uptake
-
Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid alpha-glucosidase
-
Design of potent mannose 6-phosphate analogues for the functionalization of lysosomal enzymes to improve the treatment of Pompe disease
-
Why anticancer nanomedicine needs sugars?
-
Identification of MRC2 and CD209 receptors as targets for photodynamic therapy of retinoblastoma using mesoporous silica nanoparticles
-
Mannose-6-phosphate receptor: a target for theranostics of prostate cancer
-
Targeting multiplicity: the key for anti-cancer nanoparticles